- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07350811
Retrospective, Observationnal Study to Investigate Procedural Analgesia Delivered to Patients With Lacerations, Abrasions, Burns and Leg Ulcers. (APPABU)
Retrospective and Observational Category 3 Study to Investigate Procedural Analgesia Delivered to Patients With Skin Injury, Aiming to Describe and Quantify Therapeutic Pain Control Procedures Addressing Skin Lacerations, Abrasions, Burns and Leg Ulcers.
The main part of the study is a retrospective analysis of 200 reports concerning patients with skin wounds and injuries :
- 50 consecutive patient reports dealing with skin lacerations
- 50 consecutive patient reports dealing with skin abrasions
- 50 consecutive patient reports dealing with skin burns
- 50 consecutive patient reports dealing with leg ulcers
The study comprises a complementary prospective segment, consisting of data collection from patients and from care delivery personnel, threw short interviews, in order to assess the validity of the retrospective recording on reports.
Study Overview
Status
Conditions
Detailed Description
The retrospective part of the study consists of data collection regarding care delivered to heal skin injuries.
For procedures performed in the emergency department (wound care, dermabrasions and burns), the main source of collection data will be the computerized emergency files that are completed by the doctors and that meet our objectives. For the care of leg ulcers, the main source of collection are records from vascular medicine consultations, and will be represented by the care files that are filled in by the nurses during the consultation.
In each of the four sections of the survey (wounds, dermabrasions, burns and leg ulcers), 50 "consecutive and correctly completed" acts will be included and will be collected.
Incomplete files (missing data on the procedures performed and/or treatments administered) will be replaced by the following ones in reverse chronological order. Inclusion will start with the most recent files and extend to the oldest ones. When the investigators have doubts about the understanding and correct interpretation of the information in the source files, they will discuss them with the careproviders, on an ad hoc basis and during the scheduled structured interviews.
The prospective part of the study consists of short guided interviews with patients (10-minute conversation with specific formated questions) and with care providers (15-minute conversation). The objective of the interviews is to validate, complete and/or correct the information collected threw patient reports.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Le Chesnay, France, 78150
- Hospital Versailles
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
Main retrospective study: Adult patient with skin injury (laceration, abrasion, burn or skin ulcer) whose medical report is available.
Additionnal prospective interview: Adult patient with skin injury (laceration, abrasion, burn or skin ulcer) who consents to the 10-minute interview.
Exclusion Criteria:
Main retrospective study: medical report incomplete. Additionnal prospective interview: Not french speaking.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Procedural analgesia delivered to patients with dermabrasion
Hospital reports of patients who were treated in the emergency deparment for skin abrasion
|
|
Procedural analgesia delivered to patients with skin burn
Hospital reports of patients who were treated in the emergency department for skin burn
|
|
Procedural analgesia delivered to patients with leg ulcer
Hospital reports of patients who were treated in the vascular department for leg ulcer
|
|
Procedural analgesia delivered to patients with skin lacerations
Hospital reports of patients who were treated in the emergency deparment for skin lacerations
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain level
Time Frame: Up to 30 minutes
|
Pain level ≤ 3/10 (light or no pain) on a 10-point pain scale throughout the interval starting 30 minutes after treatment initiation and ending.
|
Up to 30 minutes
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P24/05 - APPABU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Leg Ulcer
-
Kerecis Ltd.Serena GroupRecruitingVenous Leg Ulcer | Venous Ulcer | Venous Leg Ulcer (VLU) | Venous Leg | VLUUnited States
-
Nantes University HospitalCompletedHypertensive Leg UlcerFrance
-
University Hospital, Strasbourg, FranceTerminated
-
Assistance Publique - Hôpitaux de ParisCompletedMARTORELL'S ULCER | Hypertensive Leg Ulcer | Necrotic AngiodermatitisFrance
-
University of MiamiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedVenous Leg UlcerUnited States
-
Imperial College LondonImperial College Healthcare NHS TrustCompleted
-
Umeå UniversityKarolinska Institutet; Luleå University of Technology; Skellefteå MunicipalityActive, not recruitingHard-to-heal Wounds | Venous Leg Ulcer (VLU) | Arterial Leg Ulcer | Pressure Ulcer (PU)Sweden
-
Pharma 2100WithdrawnArterial Leg UlcerDenmark
-
SolasCure LimitedCompletedVenous Leg Ulcer | Leg Injuries and DisordersUnited States, Hungary, United Kingdom
-
StimLabsNot yet recruitingLeg Ulcers | Venous Leg Ulcers | Leg Ulcers Venous | Venous Leg | Venous Leg Ulcers (VLUs)